Williamson Robert F III — SEC insider filings

SEC reporting owner CIK 1397331. 19 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2023-03-17 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Perspective Therapeutics, Inc. (CATX)Director1929 legs · 568,454 sh · $547,522—6

Insider filings — Williamson Robert F III

FiledFormIssuerReported transactionsSource
2026-11-194Perspective Therapeutics, Inc. (CATX)Purchase (P): 15,000 @ $0.80EDGAR
2026-11-184Perspective Therapeutics, Inc. (CATX)Purchase (P): 25,000 @ $0.84EDGAR
2026-11-164Perspective Therapeutics, Inc. (CATX)Purchase (P): 18,609 @ $0.84 · Purchase (P): 6,289 @ $0.84EDGAR
2026-03-044Perspective Therapeutics, Inc. (CATX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-11-144Perspective Therapeutics, Inc. (CATX)Purchase (P): 9,498 @ $2.10EDGAR
2025-04-014Perspective Therapeutics, Inc. (CATX)Purchase (P): 22,192 @ $2.27 · Purchase (P): 38,145 @ $2.14EDGAR
2025-03-054Perspective Therapeutics, Inc. (CATX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-12-044/APerspective Therapeutics, Inc. (CATX)Holdings only — no transactions reportedEDGAR
2024-11-274Perspective Therapeutics, Inc. (CATX)Purchase (P): 3,647 @ $3.62 · Purchase (P): 2,619 @ $3.67EDGAR
2024-06-244Perspective Therapeutics, Inc. (CATX)Grant/award (A): 23,000 (derivative) @ $0EDGAR
2024-06-034Perspective Therapeutics, Inc. (CATX)Purchase (P): 55,000 @ $1.38EDGAR
2024-05-304Perspective Therapeutics, Inc. (CATX)Purchase (P): 11,375 @ $1.32 · Purchase (P): 18,656 @ $1.34EDGAR
2024-02-014Perspective Therapeutics, Inc. (CATX)Purchase (P): 18,579 @ $0.71 · Purchase (P): 5,127 @ $0.71 · Purchase (P): 57,121 @ $0.71 · Purchase (P): 42,879 @ $0.72 · Purchase (P): 3,500 @ $0.70EDGAR
2024-01-304Perspective Therapeutics, Inc. (CATX)Purchase (P): 12,250 @ $0.61 · Purchase (P): 14,850 @ $0.61 · Purchase (P): 8,513 @ $0.59 · Purchase (P): 25,000 @ $0.55 · Purchase (P): 50,000 @ $0.54 · Purchase (P): 4,031 @ $0.64 · +1 moreEDGAR
2024-01-264Perspective Therapeutics, Inc. (CATX)Purchase (P): 29,862 @ $0.49 · Purchase (P): 22,134 @ $0.49EDGAR
2023-12-264Perspective Therapeutics, Inc. (CATX)Purchase (P): 3,663 @ $0.33EDGAR
2023-12-194Perspective Therapeutics, Inc. (CATX)Purchase (P): 10,000 @ $0.26 · Purchase (P): 13,680 @ $0.32EDGAR
2023-12-144Perspective Therapeutics, Inc. (CATX)Grant/award (A): 230,000 (derivative) @ $0EDGAR
2023-03-174Perspective Therapeutics, Inc. (ISR)Grant/award (A): 470,000 (derivative) @ $0 · Grant/award (A): 230,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1397331 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs